MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$873,467
EPS
-$1.81
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
Research and development
61,826
116,383
General and administrative
833,304
849,182
Total operating expenses
895,130
965,565
Loss before other income (expense)
-895,130
-965,565
Interest income, net
21,663
7,740
Loss from continuing operations
-873,467
-957,825
Net loss
-873,467
-957,825
Basic EPS
-1.81
-0.45
Diluted EPS
-1.81
-0.45
Basic Average Shares
481,587
2,122,872
Diluted Average Shares
481,587
2,122,872
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$873,467
Loss from continuing
operations
-$873,467
Interest income, net
$21,663
Loss before other
income (expense)
-$895,130
Total operating
expenses
$895,130
General and
administrative
$833,304
Research and development
$61,826
Buy us a coffee
Salarius Pharmaceuticals, Inc. (SLRX)
Salarius Pharmaceuticals, Inc. (SLRX)